C Reeder
Overview
Explore the profile of C Reeder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
249
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vaxman I, Abeykoon J, Dispenzieri A, Kumar S, Buadi F, Lacy M, et al.
Blood Cancer J
. 2021 Dec;
11(12):196.
PMID: 34876555
Belantamab mafodotin is a highly selective targeted therapy for multiple myeloma. It targets the B cell maturation antigen (BCMA) on plasma cells and showed promising results in several randomized clinical...
2.
Reeder C, Huddy V, Cella M, Taylor R, Greenwood K, Landau S, et al.
Psychol Med
. 2017 Sep;
47(15):2720-2730.
PMID: 28866988
Background: Cognitive remediation (CR) is a psychological therapy, which improves cognitive and social functioning in people with schizophrenia. It is now being implemented within routine clinical services and mechanisms of...
3.
Gowin K, Kosiorek H, Dueck A, Mascarenhas J, Hoffman R, Reeder C, et al.
Leuk Res
. 2017 Jun;
60:31-35.
PMID: 28646676
Myelofibrosis is a myeloproliferative neoplasm that is characterized by splenomegaly, profound symptom burden, and cytopenias. JAK inhibitor therapy offers improvements in splenomegaly, symptom burden, and potentially survival; however, cytopenias remain...
4.
Kumar S, Mikhael J, LaPlant B, Lacy M, Buadi F, Dingli D, et al.
Bone Marrow Transplant
. 2013 Nov;
49(2):201-5.
PMID: 24185588
Initial therapy of multiple myeloma with lenalidomide-based regimens can compromise stem cell collection, which can be overcome with the addition of plerixafor. Plerixafor is typically given subcutaneously (SQ), with collection...
5.
Drake R, Day C, Picucci R, Warburton J, Larkin W, Husain N, et al.
Psychol Med
. 2013 Nov;
44(9):1889-99.
PMID: 24172842
Background: Cognitive remediation (CR) preceding cognitive-behavioural therapy for psychosis (CBTp) was trialled within routine clinical services, with the hypothesis that following first-episode non-affective psychosis CR would enhance CBTp efficacy by...
6.
Cella M, Swan S, Medin E, Reeder C, Wykes T
Psychol Med
. 2013 Jun;
44(3):469-76.
PMID: 23734941
Background: People with a diagnosis of schizophrenia have limited metacognitive awareness of their symptoms. This is also evident for cognitive difficulties when neuropsychological assessments and self-reports are compared. Unlike for...
7.
Paripati H, Stewart A, Cabou S, Dueck A, Zepeda V, Pirooz N, et al.
Leukemia
. 2008 Jan;
22(6):1282-4.
PMID: 18216870
No abstract available.
8.
Weller C, Reeder C
J Am Osteopath Assoc
. 2001 May;
101(5):284-7.
PMID: 11381564
Pseudoaneurysms of the superficial temporal artery are a rare and potentially critical cause of facial masses. Most pseudoaneurysms form as a result of blunt trauma and present as painless, pulsatile...
9.
Wykes T, Reeder C, Corner J
Schizophr Res
. 2000 Dec;
46(2-3):241-53.
PMID: 11120436
The current study investigates whether an executive processing measure, response inhibition, is stable over time and across new samples of patients with schizophrenia. Two groups of patients (with and without...
10.
Wykes T, Reeder C, Corner J, Williams C, Everitt B
Schizophr Bull
. 1999 Jul;
25(2):291-307.
PMID: 10416732
Approaches to cognitive remediation have differed across studies. Most of the larger studies have concentrated on group treatments designed without the benefit of recent laboratory-based studies. The current study describes...